NeuroLucent, Inc is a biotechnology startup company focused on developing novel therapeutic strategies for the prevention and treatment of neurodegenerative disorders such as Alzheimer’s disease. The company’s expertise extends from medicinal chemistry development and formulation to biological assays and screening using cutting edge technology.